MedPath

Whole genome analysis and gene expression profiling using peripheral blood cells to establish a new method for evaluation of medical diseases.

Not Applicable
Conditions
Type 2 diabetes, hypertension, dyslipidemia, obesity, etc.
Registration Number
JPRN-UMIN000051647
Lead Sponsor
Kanazawa university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Pregnant women.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body composition, body weight, BMI, and blood pressure. HbA1c, laboratory evaluations, including hematology, serum chemistry, 75g OGTT. Gene expression profiling of peripheral blood cells. To analyze the association between gene excretion and biomarkers over an 8-year period.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath